Chronic obstructive pulmonary disease (COPD) is a disease in which airflow obstruction in the lung makes it difficult for patients to breathe. Although COPD occurs predominantly in smokers, there are still deficits in our understanding of the additional risk factors in smokers. To gain a deeper understanding of the COPD molecular signatures, we used Sparse Multiple Canonical Correlation Network (SmCCNet), a recently developed tool that uses sparse multiple canonical correlation analysis, to integrate proteomic and metabolomic data from the blood of 1008 participants of the COPDGene study to identify novel protein–metabolite networks associated with lung function and emphysema. Our aim was to integrate -omic data through SmCCNet to build interpretable networks that could assist in the discovery of novel biomarkers that may have been overlooked in alternative biomarker discovery methods. We found a protein–metabolite network consisting of 13 proteins and 7 metabolites which had a −0.34 correlation (p-value = 2.5 × 10−28) to lung function. We also found a network of 13 proteins and 10 metabolites that had a −0.27 correlation (p-value = 2.6 × 10−17) to percent emphysema. Protein–metabolite networks can provide additional information on the progression of COPD that complements single biomarker or single -omic analyses.
Cigarette smoking (CS) and genetic susceptibility determine the risk for development, progression, and severity of chronic obstructive pulmonary diseases (COPD). We posited that an incidental balanced reciprocal chromosomal translocation was linked to a patient’s risk of severe COPD. We determined that 46,XX,t(1;4)(p13.1;q34.3) caused a breakpoint in the immunoglobulin superfamily member 3 (IGSF3) gene, with markedly decreased expression. Examination of COPDGene cohort identified 14 IGSF3 SNPs, of which rs1414272 and rs12066192 were directly and rs6703791 inversely associated with COPD severity, including COPD exacerbations. We confirmed that IGSF3 is a tetraspanin-interacting protein that colocalized with CD9 and integrin B1 in tetraspanin-enriched domains. IGSF3-deficient patient–derived lymphoblastoids exhibited multiple alterations in gene expression, especially in the unfolded protein response and ceramide pathways. IGSF3-deficient lymphoblastoids had high ceramide and sphingosine-1 phosphate but low glycosphingolipids and ganglioside levels, and they were less apoptotic and more adherent, with marked changes in multiple TNFRSF molecules. Similarly, IGSF3 knockdown increased ceramide in lung structural cells, rendering them more adherent, with impaired wound repair and weakened barrier function. These findings suggest that, by maintaining sphingolipid and membrane receptor homeostasis, IGSF3 is required for cell mobility–mediated lung injury repair. IGSF3 deficiency may increase susceptibility to CS-induced lung injury in COPD.
High-throughput data such as metabolomics, genomics, transcriptomics, and proteomics have become familiar data types within the “-omics” family. For this work, we focus on subsets that interact with one another and represent these “pathways” as graphs. Observed pathways often have disjoint components, i.e., nodes or sets of nodes (metabolites, etc.) not connected to any other within the pathway, which notably lessens testing power. In this paper we propose the Pathway Integrated Regression-based Kernel Association Test (PaIRKAT), a new kernel machine regression method for incorporating known pathway information into the semi-parametric kernel regression framework. This work extends previous kernel machine approaches. This paper also contributes an application of a graph kernel regularization method for overcoming disconnected pathways. By incorporating a regularized or “smoothed” graph into a score test, PaIRKAT can provide more powerful tests for associations between biological pathways and phenotypes of interest and will be helpful in identifying novel pathways for targeted clinical research. We evaluate this method through several simulation studies and an application to real metabolomics data from the COPDGene study. Our simulation studies illustrate the robustness of this method to incorrect and incomplete pathway knowledge, and the real data analysis shows meaningful improvements of testing power in pathways. PaIRKAT was developed for application to metabolomic pathway data, but the techniques are easily generalizable to other data sources with a graph-like structure.
Down syndrome (DS), caused by trisomy 21 (T21), results in immune and metabolic dysregulation. People with DS experience co-occurring conditions at higher rates than the euploid population. However, the interplay between immune and metabolic alterations and the clinical manifestations of DS are poorly understood. Here, we report an integrated analysis of immunometabolic pathways in DS. Using multi-omics data, we infered cytokine-metabolite relationships mediated by specific transcriptional programs. We observed increased mediation of immunometabolic interactions in those with DS compared to euploid controls by genes in interferon response, heme metabolism, and oxidative phosphorylation. Unsupervised clustering of immunometabolic relationships in people with DS revealed subgroups with different frequencies of co-occurring conditions. Across the subgroups, we observed distinct mediation by DNA repair, Hedgehog signaling, and angiogenesis. The molecular stratification associates with the clinical heterogeneity observed in DS, suggesting that integrating multiple omic profiles reveals axes of coordinated dysregulation specific to DS co-occurring conditions.
Heterogeneous biomedical knowledge networks (hetnets) integrate disparate data types, drugs, genes, diseases, and pathways, across independent sources; Hetionet ( https://het.io ) is a widely used example. A standard approach for assessing connectivity significance is XSwap, which permutes the hetnet P times and fits a gamma-hurdle null model to the degree-weighted path count (DWPC), pooling permuted values across pairs with matching source and target degrees to increase the effective sample size. This permutation approach has been highly successful in practice, but it faces four practical constraints in large graphs: (1) a finite resolution for the smallest reportable p -values, (2) computational cost that grows prohibitive at path lengths L ≥ 4 or 5, (3) a variance model (Var ∝ µ2 ) that departs from the configuration-model form (1 + κ ) µ , and (4) O ( P 10 m L ) runtime. To complement this approach, we present HetNetEX (Heterogeneous Network EXact inference), which computes the null DWPC distribution analytically from degree sequences using the configuration model in O ( Ln ) time. In simulations at P = 200 across L = 1–4, HetNetEX achieves Spearman ρ > 0.96 concordance with XSwap rankings while being > 10,000× faster and providing analytical p -values without a resolution ceiling. High-degree pairs show larger XSwap sampling error than low-degree pairs, reflecting the finite-sample nature of permutation that analytical computation avoids.
Motivation: Disruption in normal gene expression can contribute to the development of diseases and chronic conditions. However, identifying disease-specific gene signatures can be challenging due to the presence of multiple co-occurring conditions and limited sample sizes. Unsupervised representation learning methods, such as matrix decomposition and deep learning, simplify high-dimensional data into understandable patterns, but often do not provide clear biological explanations. Incorporating prior biological knowledge directly can enhance understanding and address small sample sizes. Nevertheless, current models do not jointly consider prior knowledge of molecular interactions and sample labels. Results: We present GRACKLE, a novel nonnegative matrix factorization approach that applies Graph Regularization Across Contextual KnowLedgE. GRACKLE integrates sample similarity and gene similarity matrices based on sample metadata and molecular relationships, respectively. Simulation studies show GRACKLE outperformed other NMF algorithms, especially with increased background noise. GRACKLE effectively stratified breast tumor samples and identified condition-enriched subgroups in individuals with Down syndrome. The model's latent representations aligned with known biological patterns, such as autoimmune conditions and sleep apnea in Down syndrome. GRACKLE's flexibility allows application to various data modalities, offering a robust solution for identifying context-specific molecular mechanisms in biomedical research. Availability and implementation: GRACKLE is available at: https://github.com/lagillenwater/GRACKLE.